Friday, September 4

12:15 – 12:35 pm

Paper Presentation: Outcomes of Serious Illness on Nurses, Patients, and Families—Keeping a Positive Outlook – Strategies, Threats, and Outcomes for Parents of Children with Cancer and Other Serious Illness (225-1)

Parents who make end-of-life decisions for their seriously ill children do so according to their individual definitions of ‘being a good parent’ to their seriously ill child. This pediatric cancer nursing concept, developed by Pamela Hinds, has been applied to parents of critically ill children but has potential relevance for other pediatric contexts.

Speaker:
Katherine Kelly, PhD APRN PCNS-BC CPON®
CNE Hours
0.33
12:35 – 12:55 pm

Paper Presentation: Outcomes of Serious Illness on Nurses, Patients, and Families—Inpatient Deaths of Children with Cancer: DNAR and CPR Events in Children Who Don’t Survive to Hospital Discharge (225-2)

Death in children with malignancy may result from refractory disease or acute complications during therapy. In this population, little is known about the medical interventions received in the last week of life from the overall cohort of children who die from cancer or related complications as inpatients. Perceptions of under- or over-treatment can cause distress among families and staff, yet the prevalence of do not attempt resuscitation (DNAR) orders, use of CPR, and other supportive therapies remains poorly described.

Speaker:

Liza-Marie Johnson, MD MPH MSB HEC-C

Belinda Mandrell, PhD RN CPNP

CNE Hours
0.33
12:55 – 1:15 pm

Paper Presentation: Outcomes of Serious Illness on Nurses, Patients, and Families—Posttraumatic Stress Disorder (PTSD) in Nurses: An Integrative Review (225-3)

"Post-traumatic stress disorder (PTSD) is a psychiatric disorder that can occur from direct or indirect exposure to traumatic events. Nurses are at risk of developing PTSD due to their indirect and/or direct exposure to traumatic situations while providing care to vulnerable patient populations.

Speaker:
Michelle Schuster, MSN RN CPHON®
CNE Hours
0.34
12:15 – 1:15 pm

High Risk Neuroblastoma in the new decade: Incorporating targeted therapies to maximize impact in current Children’s Oncology Group trials (C226)

coglogoWhile the overall cure rate for childhood cancer is approaching 80%, the prognosis for long-term survival for children with high risk neuroblastoma lags considerably behind, at 50%–60%. Upfront standard treatment for high-risk neuroblastoma protocols within the Children’s Oncology Group (COG) has historically utilized all available modalities of cancer treatment including chemotherapy, surgery, myeloablative chemotherapy with stem cell rescue, radiation therapy, differentiating agents, and most recently biologic therapy with anti-GD2 antibody (dinutuximab) used post consolidation in ANBL0032.

Speaker:

Wendy Fitzgerald, MSN APRN PPCNP-BC

Denise Mills, MN RN(EC) NP CPHON®

CNE Hours
1